Feasibility of the Latella Implant System for Medial Osteoarthritis (OA)
Not Applicable
Terminated
- Conditions
- Osteoarthritis
- Registration Number
- NCT02002637
- Lead Sponsor
- Cotera, Inc.
- Brief Summary
The objective of this study is to evaluate the safety and technical feasibility of implanting the Latella Implant System in the treatment of patients with medial osteoarthritis of the knee.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 11
Inclusion Criteria
- History of pain as due to medial osteoarthritis
Exclusion Criteria
- Rheumatoid arthritis
- Joint or ligament instability
- Metal ion allergy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Freedom from unanticipated serious adverse device effects 12 Months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms by which the Latella Implant System offloads the medial condyle in knee osteoarthritis?
How does the Latella Knee Implant System compare to unicompartmental knee arthroplasty for medial osteoarthritis treatment?
What biomechanical biomarkers predict successful iliotibial band lateralization outcomes in NCT02002637?
What adverse events were observed in the Cotera, Inc. Latella Implant System safety study for medial OA?
Are there alternative orthopedic devices to the Latella Implant System for medial compartment knee osteoarthritis?
Trial Locations
- Locations (2)
Slotervaart Hospital
🇳🇱Amsterdam, Netherlands
Barts Health NHS Trust
🇬🇧London, United Kingdom
Slotervaart Hospital🇳🇱Amsterdam, Netherlands